EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib by Pao William, Miller Vincent, Zakowski Maureen, Doherty Jennifer, Politi Katerina, Sarkaria Inderpal, Singh Bhuvanesh, Heelan Robert, Rusch Valerie, Fulton Lucinda, Mardis Elaine, Kupfer Doris, Wilson Richard, Kris Mark, Varmus Harold in Proceedings of the National Academy of Sciences of the United States of America (2004).

[PMID: 15329413] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.